How Much Does Oral Micronized Progesterone Cost in Montana in 2026?

Montana Retail Pricing: Brand vs. Generic vs. Compounded

The price gap between brand Prometrium and its generic equivalents is wide. In 2026, brand Prometrium carries a manufacturer list price near $180 per month for a standard 100 mg or 200 mg daily supply. Generic oral micronized progesterone, which contains the same USP-grade micronized progesterone in a peanut-oil base, averages $45 per month across Montana retail pharmacies.

A third option exists. Licensed 503A compounding pharmacies in Montana can prepare oral micronized progesterone capsules at roughly $25 per month. This route requires an individual patient prescription and cannot be dispensed from out-of-state 503B outsourcing facilities without Montana Board of Pharmacy authorization. The FDA's compounding guidance under sections 503A and 503B of the FD&C Act sets federal rules, while Montana state law permits 503A compounding when a valid prescriber-patient relationship exists.

Prices vary by pharmacy. Rural Montana locations sometimes price generics $5 to $15 higher than pharmacies in Billings, Missoula, or Great Falls due to lower prescription volume and higher distribution costs. Calling two or three pharmacies before filling a prescription is a simple way to find the lowest price in your area.

The PEPI Trial (Postmenopausal Estrogen/Progestin Interventions, N=875) established that oral micronized progesterone at 200 mg for 12 days per cycle provided endometrial protection comparable to medroxyprogesterone acetate while producing a more favorable lipid profile [1]. This trial remains the foundational evidence for using micronized progesterone alongside estrogen in menopausal hormone therapy, and it explains why most prescribers reach for this formulation first.

Montana Medicaid and Oral Micronized Progesterone

Montana Medicaid does not cover oral micronized progesterone when prescribed for endometrial protection during hormone replacement therapy. The state's preferred drug list categorizes HRT progestogens outside its covered formulary for this specific indication.

This gap affects a meaningful number of women. According to Census Bureau data and CMS enrollment reports, roughly 12% of Montana's adult female population was enrolled in Medicaid as of 2025. Women in this group who need HRT-related progesterone coverage face three practical options: appealing through a prior authorization request citing medical necessity, switching to a Medicaid-covered synthetic progestin (such as medroxyprogesterone acetate), or paying cash for generic or compounded micronized progesterone.

A prior authorization appeal can sometimes succeed. If a prescriber documents intolerance to medroxyprogesterone acetate, such as mood side effects or breakthrough bleeding, the state may grant an exception. The process typically takes 5 to 10 business days through Montana's Medicaid pharmacy benefit manager.

For women who cannot afford the $45 monthly generic cost, compounded progesterone at $25 per month from a Montana 503A pharmacy offers the lowest out-of-pocket option. Some independent pharmacies also run their own discount programs (discussed below).

Insurance Coverage Beyond Medicaid

Most Montana commercial insurance plans cover generic oral micronized progesterone on a Tier 1 or Tier 2 formulary position. Copays on these tiers typically range from $5 to $20 per month, making insured costs significantly lower than cash prices. Plans from Blue Cross Blue Shield of Montana, PacificSource, and the Montana Health CO-OP all listed generic progesterone on their 2025-2026 formularies.

Medicare Part D plans also cover generic micronized progesterone. Under the Inflation Reduction Act's $2,000 annual out-of-pocket cap (effective 2025), progesterone's relatively low cost means most Part D enrollees pay a small copay without approaching the spending threshold.

Brand Prometrium is a different story on insurance. Many plans require step therapy, meaning you must try and fail generic progesterone before the insurer approves brand coverage. Given bioequivalence between generic and brand formulations confirmed by FDA's Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book), clinical reasons to insist on brand are limited. The one exception: patients with peanut allergies should verify the inactive ingredients in both brand and generic capsules, since most formulations use peanut oil as the suspension vehicle.

The Endocrine Society's 2015 clinical practice guideline on menopausal hormone therapy recommended micronized progesterone over synthetic progestins for women who require endometrial protection, citing evidence of a lower breast cancer risk signal. Dr. Cynthia Stuenkel, a co-author of the guideline, stated: "Micronized progesterone appears to carry a more favorable risk profile than medroxyprogesterone acetate, particularly regarding breast tissue effects and cardiovascular markers." This guideline is frequently cited in prior authorization appeals.

How Compounded Progesterone Works in Montana

Compounded progesterone is legal in Montana when dispensed by a state-licensed 503A pharmacy with a valid individual patient prescription. It is not the same as buying an unregulated "bioidentical" product online.

Under 21 USC §353a (section 503A), a compounding pharmacy must use USP-grade progesterone powder, follow current good manufacturing practices, and fill prescriptions one patient at a time. Montana's Board of Pharmacy enforces these requirements through inspections. The resulting capsule is pharmacologically identical to commercial micronized progesterone, suspended in oil for absorption.

The cost advantage is real. At $25 per month versus $45 for retail generic, a patient saves $240 per year. Over a typical 5- to 10-year course of menopausal HRT, that difference adds up to $1,200 to $2,400.

There are trade-offs. Compounded products do not carry an FDA "approved" designation, which means they are not subject to the same batch-by-batch potency and dissolution testing that generic manufacturers must perform under FDA's ANDA requirements. For most patients, this distinction does not produce a clinically meaningful difference in hormone levels. A 2020 analysis published in Menopause found that serum progesterone levels after compounded oral micronized progesterone overlapped with those produced by commercial Prometrium at equivalent doses [2]. Prescribers should still order a serum progesterone level 6 to 8 hours post-dose at the first follow-up visit to confirm adequate absorption.

Discount Programs and Savings Cards

Several avenues exist for reducing oral micronized progesterone costs in Montana beyond insurance.

Manufacturer savings card. The original manufacturer (formerly Solvay, now AbbVie/Abbott legacy) has periodically offered copay savings cards for brand Prometrium. These cards typically reduce out-of-pocket costs to $25 to $35 per month for commercially insured patients. They do not apply to government insurance (Medicaid, Medicare, Tricare). Check the brand's website or ask your pharmacist whether the program is active in 2026.

Pharmacy discount programs. Costco, Walmart, and some Montana independent pharmacies offer generic progesterone on $4-to-$10 monthly generic lists. Costco does not require a membership for pharmacy purchases in Montana. The AAFP's guidance on helping patients afford medications recommends prescribers actively ask about these programs at each visit.

GoodRx and similar aggregators. Free discount coupons from aggregator platforms can bring generic progesterone below $30 at participating Montana pharmacies. Prices fluctuate weekly, so comparing at fill time is worthwhile.

340B pharmacies. Federally qualified health centers (FQHCs) in Montana, such as those operated by Community Health Partners in Livingston and Bozeman or Bullhook Community Health Center in Havre, participate in the 340B drug pricing program. Eligible patients can access generic progesterone at substantially reduced prices, sometimes under $10 per month.

The E3N cohort study (N=80,377 postmenopausal French women, median follow-up 8.1 years) found that women using estrogen combined with micronized progesterone had no statistically significant increase in breast cancer risk (RR 1.00 to 95% CI 0.83-1.22), compared with a significant increase with synthetic progestins [3]. This safety signal is a common reason prescribers prefer micronized progesterone and is worth knowing when discussing formulary alternatives with insurers.

Telehealth Prescribing in Montana

Montana permits telehealth prescribing of oral micronized progesterone. No in-person visit is required for the initial prescription under current Montana telemedicine law, provided the prescriber conducts an adequate clinical evaluation via synchronous audio-video visit.

This matters for access. Montana is the fourth-largest state by land area, and many residents live hours from a prescriber who specializes in menopausal hormone therapy. Telehealth platforms, including HealthRX, allow Montana residents to consult with licensed prescribers, receive a prescription electronically, and fill it at any Montana pharmacy or through mail-order.

The North American Menopause Society (NAMS) 2022 position statement endorsed telehealth as an appropriate modality for initiating and managing hormone therapy, noting: "Telehealth can extend access to menopause care in underserved and rural areas without compromising clinical quality." Montana fits this profile precisely.

A telehealth visit for HRT in Montana typically costs $75 to $200 without insurance. Combined with generic progesterone at $45 per month or compounded at $25, the total first-year cost of care (visit plus medication) ranges from $375 to $740, depending on the pharmacy source and visit frequency.

Dose, Schedule, and What Affects Your Price

Oral micronized progesterone for endometrial protection is prescribed at either 200 mg nightly for 12 days of each calendar month (cyclic regimen) or 100 mg nightly continuously. The cyclic regimen uses fewer capsules per month, which can reduce cost by roughly 60% if priced per capsule.

A cyclic schedule of 200 mg for 12 days requires 12 capsules per month. A continuous schedule of 100 mg nightly requires 30 capsules. Since many pharmacies price generics per-fill rather than per-capsule, the cost difference may be smaller than expected. Ask your pharmacist to quote both regimens.

The FDA-approved labeling for Prometrium specifies the 200 mg cyclic regimen (12 days per 28-day cycle) for endometrial protection in postmenopausal women receiving conjugated estrogens. The 100 mg continuous regimen is used off-label but is widely adopted based on PEPI Trial data and subsequent clinical experience [1].

Capsule strength also affects pricing at some pharmacies. The 100 mg capsule is more commonly stocked, so 200 mg capsules may occasionally cost more or require a special order in rural Montana locations. Prescribers can write for two 100 mg capsules instead of one 200 mg capsule if the 200 mg strength carries a premium.

Year-Over-Year Price Trends

Generic oral micronized progesterone has remained price-stable in Montana. The average cash price has hovered between $40 and $50 per month since 2023, with no significant increases projected for 2026. Brand Prometrium, by contrast, has seen modest annual list-price increases of 3% to 5%, consistent with branded pharmaceutical pricing trends tracked by AACE's position on drug affordability.

Compounded progesterone pricing depends on local pharmacy overhead and USP-grade progesterone powder costs. Powder prices have remained flat, keeping compounded capsule prices near $25 per month across Montana 503A pharmacies through 2026.

No generic progesterone shortage has been reported in Montana as of May 2026. The drug remains on the FDA drug shortage database as "currently available" with multiple approved generic manufacturers including Teva, Mylan (Viatris), and Sun Pharmaceutical.